TNF-α-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts

Immunology

Volumn 89, Issue 4, 1996, Pages 553-557

  Migita, K ^a   Eguchi, K ^a   Kawabe, Y ^a   Ichinose, Y ^a   Tsukada, T ^a   Aoyagi, T ^b   Nakamura, H ^a   Nagataki, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ureshino Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FIBROBLAST; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0029963757     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-789.x     Document Type: Article

References (26)

1. OKADA Y., NAGASE H. & HARRIS E.D. JR (1983) A metalloproteinase from rheumatoid synovial fibroblasts that digests connective tissue matrix components, purification and characterization. J Biol Chem 261, 14245.
2. OKADA Y., TAKEUCHI N., TOMITA K., NAKANISHI I. & NAGASE H. (1989) Immunolocalization of matrix metalloproteinase 3(stromelysin) in rheumatoid synovial fibroblasts (B cells): correlation with rheumatoid arthritis. Annu Rheum Dis 48, 645.
3. UNEMORI E.N., HIBBS M.S. & AMENTO E.P. (1991) Constitutive expression of a 92-kD Gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88, 1656.
4. HEMBRY R.M., BAGGA M.R., REYNOLDS J.J. & HAMBLEN D.L. (1995) Immunolocalisation of six matrix metalloproteinases and their inhibitors, TIMP-2 and TIMP-2 in synovia from patients with osteoand rheumatoid arthritis. Ann Rheum Dis 54, 25.
5. WALAKOVITS L.A., MOORE V.L., BHARDWAJ N., GALLICK G.S. & LARK M.W. (1992) Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee joint injury. Arthritis Rheum 35, 35.
6. WOLFE G.C., MACNAUL K.L., BUECHEL F.F. et al. (1993) Differential in vivo expression of collaganese messenger RNA in synovium and cartilage: quantitative comparison with stromelysin in osteoarthritis patients and in two animal models of acute inflammatory arthritis. Arthritis Rheum 36, 1540.
7. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 162, 2163.
8. 2 production by human synovial cells. J Exp Med 77, 645.
9. MATRISIAN L.M. (1990) Metalloproteinase and their inhibitors in tissue remodelling. Trends Genet 6, 121.
10. SPRINGMAN E.B. (1990) Multiple modes of activators of latent human fibroblast collagenase: evidence for the role of Cys 73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc Natl Acad Sci USA 87, 364.
11. SUZUKI K., ENGHILD J.J., MORODOMI T., SALVESEN G. & NAGASE H. (1990) Mechanism of activation of tissue procollagenase by matrix metalloproteinase 3(stromelysin). Biochemistry 29, 10261.
12. OKADA Y., GONOJI Y., NAKATA K. et al. (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells, purification and activation of the precursor and enzymatic properties. J Biol Chem 267, 21712.
13. WARD R.V., ATKINSON S.J., SLOCOMBE P.M., DOCHERTY A.J., REYNOLDS J.J. & MURPHY G. (1991) Tissue inhibitor of metalloproteinase-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim Biophys Acta 1079, 242.
14. MORODOMI T., SUZUKI K., SASAGURI Y., MORIMOTO M. & NAGASE H. (1992) Comparative studies of a 92 kDa gelatinolytic metalloproteinase from U937 cells and matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Matrix Supplement 1, 87.
15. STRONGIN A.Y., MARMER B.L., GRANT G.A. & GOLDBERG G.I. (1993) Plasma membrane-dependent activation of the 72 kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268, 14033.
16. OVERALL C.M. & SODEK J. (1990) Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase and Pump-1 is accompanied by the tissue inhibitors of matrix metalloproteinase. J Biol Chem 265, 21 141.
17. BROWN P.D., LEVY A.T., MARGULIES I.M., STETLER-STEVENSON W.G. & LIOTTA L.A. (1990) Independent expression and cellular processing of Mr 72000 type IV collagenase and interstitial collagenase in human tumorgenic cell lines. Cancer Res 50, 6184.
18. BROWN P.D., KLEINER D.E., UNSWORTH E.J. & STETLER-STEVENSON W.G. (1993) Cellular activation of the 7 kDa type IV procollagenase/TIMP-2 complex. Kidney Int 43, 163.
19. SATO H., TAKINO T., OKADA Y. et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61.
20. YU M., SATO H., SEIKI M. & THOMPSON E.W. (1995) Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by Concanavaline A in MDA-MB-231 human breast cancer cells. Cancer Res 55, 3272.
21. ZVAIFLER N.J. & FIRESTEIN G.C. (1994) Pannus and pannocytes. Alternative models of destruction in rheumatoid arthritis. Arthritis Rheum 37, 783.
22. ULFGREN A.K., LINDBLAG S., KLARESKOG L., ANDERSSON J. & ANDERSSON U. (1995) Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 54, 654.
23. FARAHAT M.N., YANNI G., POSTON R. & PANNAYI G.S. (1993) Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 52, 870.
24. CHU C.Q., FIELD M., FELDMANN M. & MAINI R.N. (1991) Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 35, 1125.
25. 2) versus placebo on rheumatoid arthritis. Lancet 344, 1105.
26. 2) in patients with rheumatoid arthritis. Lancet 344, 1125.